Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1207, 2008-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
FDA requests class label change for atypical antipsychotics
Inpharma, Vol. 1, Iss. 1406, 2003-01 ,pp. :
Access to resources
Recommend
US FDA orders boxed warning for all glitazones
Reactions Weekly, Vol. 1, Iss. 1165, 2007-01 ,pp. :
US FDA requires boxed warning and REMS for metoclopramide
Reactions Weekly, Vol. 1, Iss. 1242, 2009-01 ,pp. :
US FDA orders boxed warning for all glitazones
Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. :
US FDA to enhance warnings on antidepressant labelling
Reactions Weekly, Vol. 1, Iss. 1020, 2004-01 ,pp. :